Given adiponectin’s anti-diabetic, anti-atherosclerotic, and anti-inflammatory effects, we believe that OKE may improve obesity and related metabolic diseases by reducing adipogenic differentiation and increasing adiponectin expression [34]. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.